Royal Bank of Canada Doubles Down on Artivion with Significant Share Purchase
Artivion, Inc., a global medical technology company, saw its stake in the company increase by 73.1% in the first quarter due to a purchase of 39,553 additional shares by Royal Bank of Canada.
The institutional investor now owns 93,676 shares of Artivion's stock, representing 0.19% of the company's total value of $3,430,000 as per its most recent SEC filing with the Securities and Exchange Commission.
Other hedge funds have also modified their holdings in Artivion, including Caitong International Asset Management Co. Ltd., Rockefeller Capital Management L.P., Larson Financial Group LLC, Smartleaf Asset Management LLC, and KBC Group NV, who collectively own 86.37% of the stock.